| SKU | ISG009953 |
| Brand | Flumox |
| Categories | Medication & Treatments |
| Concentrations | 500 Mg |
| Shop by Concerns | ENT Infections |
| Gender | Neutral |
| Shop By Goals | Bacterial Infection Treatment |
| Imported Or Local | Local |
| Ingredient | Amoxicillin Flucloxacillin |
| UPC | 6221032311344 |
| Product Form | vials |
| Specialty | Broad Spectrum Hospital Use Prescription only |
| Sub Categories | Anti Inflammatory And Anti Antibiotic |
| Warning | allergy risk for fish or seafood Allergy to probiotics or capsule components Risk of Severe Allergic Reaction Use under medical supervision only |
Flumox 500 Mg Vials
Description:
Flumox 500 mg vials are a prescription injectable antibiotic medication containing a combination of amoxicillin and flucloxacillin, manufactured by EIPICO. It is used in hospitals and clinical settings for the treatment of moderate to severe bacterial infections when parenteral (injectable) therapy is required. The combination of amoxicillin (a broad-spectrum penicillin) and flucloxacillin (a penicillinase-resistant penicillin) provides enhanced coverage against a wide range of gram-positive and gram-negative bacteria, including beta-lactamase-producing strains. Flumox 500 mg is typically administered by intramuscular (IM) or intravenous (IV) injection under medical supervision to rapidly control infections of the respiratory tract, urinary tract, skin and soft tissues, pelvic and gynecological organs, and ear, nose and throat (ENT) structures.
Indications:
- Acute and chronic bronchitis caused by susceptible bacteria.
- Community-acquired and hospital-acquired pneumonia where a penicillin-sensitive organism is suspected or confirmed.
- Urinary tract infections (UTIs), including cystitis and pyelonephritis due to susceptible organisms.
- Ear, nose and throat infections such as otitis media, sinusitis, tonsillitis, and pharyngitis caused by sensitive bacteria.
- Skin and soft tissue infections, including cellulitis, abscesses, wound infections, and infected burns.
- Pelvic inflammatory disease (PID) and other pelvic infections due to susceptible organisms.
- Gynaecological infections, including post‑operative or post‑partum infections where indicated.
- Other infections caused by organisms sensitive to amoxicillin, flucloxacillin, or their combination, as assessed by the treating physician.
Active Ingredients / Key Components:
- Amoxicillin – 250 mg per vial (exact ratio may vary by manufacturer presentation; precise concentration information is not available in the provided data).
- Flucloxacillin – 250 mg per vial (exact ratio may vary by manufacturer presentation; precise concentration information is not available in the provided data).
- Excipients: Other inactive ingredients used for powder formulation for injection (full excipient list and exact concentrations are not available in the provided data).
Dosage & Administration / How to Use:
- Flumox 500 mg vials are for parenteral use only and must be administered by a healthcare professional.
- Route of administration: Intramuscular (IM) injection or intravenous (IV) injection/infusion, as directed by the physician.
- Typical adult dosage: The dose and frequency depend on the type, site, and severity of infection, as well as patient weight, age, and kidney function. Common regimens may involve 500 mg every 6–8 hours, but the exact dose must be determined by the treating doctor.
- Paediatric dosage: Dose is usually calculated based on body weight (mg/kg/day) divided into several doses; to be determined strictly by a paediatrician.
- Reconstitution: The powder in the vial must be reconstituted with a suitable diluent (e.g., sterile water for injection or compatible IV solution) according to the manufacturer’s instructions. The exact volume and method of reconstitution are not available in the provided data and must be taken from the official package insert.
- Duration of treatment: Typically 5–14 days depending on infection type and clinical response. Therapy should continue for at least 2–3 days after symptoms resolve, as advised by the physician.
- Do not self-inject. Use only under medical supervision in a clinic or hospital setting.
- Patients with renal or hepatic impairment may require dose adjustment; this must be assessed by the doctor.
Clinical Benefits:
- Provides broad-spectrum antibacterial coverage by combining amoxicillin with flucloxacillin, effective against many gram-positive and gram-negative organisms.
- Offers enhanced activity against beta-lactamase-producing bacteria, reducing the risk of treatment failure due to resistance.
- Suitable for moderate to severe infections where rapid and reliable parenteral antibiotic therapy is required.
- Effective in treating respiratory tract, urinary tract, skin and soft tissue, pelvic, gynecological, and ENT infections caused by susceptible organisms.
- Helps reduce infection-related symptoms such as fever, pain, inflammation, productive cough, and local redness or swelling when used as directed.
Warnings & Contraindications:
- Contraindicated in patients with known hypersensitivity or allergy to amoxicillin, flucloxacillin, other penicillins, or any component of the formulation.
- Use with extreme caution in patients with a history of severe allergic reactions (e.g., anaphylaxis) to beta-lactam antibiotics (penicillins, cephalosporins, carbapenems).
- Patients with hepatic impairment, cholestatic jaundice, or a history of flucloxacillin-associated liver dysfunction should be monitored closely; use may be contraindicated in severe liver disease.
- Renal impairment may require dose adjustment; consult a nephrologist or follow standard dosing guidelines for reduced kidney function.
- May cause Clostridioides difficile-associated diarrhea; discontinue and seek medical advice if severe, persistent, or bloody diarrhea occurs.
- Consult your doctor before use if pregnant or nursing. Penicillins are generally considered relatively safe in pregnancy and lactation, but use should always be based on a risk–benefit assessment by the physician.
- Inform your doctor about all medications you are taking, especially other antibiotics, anticoagulants (e.g., warfarin), methotrexate, and probenecid, as interactions may occur.
- Not intended for self-medication. Use only on prescription and under medical supervision.
- Not intended to diagnose, treat, cure, or prevent any disease without proper medical evaluation.
- Keep out of reach of children.
Side Effects:
- Common side effects: Nausea, vomiting, diarrhea, abdominal discomfort, mild skin rash, and injection site pain or irritation.
- Allergic reactions: Urticaria (hives), itching, angioedema, and, rarely, severe anaphylactic reactions. Seek immediate medical attention if difficulty breathing, swelling of face/lips/tongue, or severe rash occurs.
- Hepatic effects: Elevated liver enzymes, cholestatic jaundice, or hepatitis have been reported with flucloxacillin-containing products; contact your doctor if you notice yellowing of the skin or eyes, dark urine, or persistent fatigue.
- Hematologic effects (rare): Changes in blood counts such as anemia, leukopenia, thrombocytopenia; monitoring may be required in prolonged therapy.
- Superinfection: Prolonged use may lead to overgrowth of non-susceptible organisms, including fungi; inform your doctor if new symptoms appear during treatment.
- If any side effects are severe, persistent, or worrying, or if you experience any unexpected symptoms, contact your healthcare provider immediately.
Storage Instructions:
Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Reconstituted solutions should be used within the time frame specified in the official product leaflet; discard any unused portion as directed by healthcare facility protocols.
Specifications:
- Product type: Prescription antibiotic medicine for injection.
- Form: Powder for solution for injection in vial.
- Strength: 500 mg total antibiotic content per vial (amoxicillin + flucloxacillin; exact ratio not available in the provided data).
- Route of administration: Intramuscular (IM) or intravenous (IV) use only.
- Intended users: Adults and children as prescribed by a physician.
- Manufacturer: EIPICO (Egyptian International Pharmaceutical Industries Co.).
Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.
